Cours suspendu

Autres langues Applied Therapeutics, Inc.

Actions

APLT

US03828A1016

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 02/02/2026			Varia. 5j.	Varia. 1 janv.
0,1030 ^USD	+0,19%		-.--%	+3,00%

03/02	Cycle Group Holdings Limited finalise l'acquisition d'Applied Therapeutics, Inc. (NasdaqCM:APLT) pour environ 14,3 millions de dollars	CI
03/02	Applied Therapeutics, Inc. annonce des changements au sein de sa direction	CI

Autres langues

03/02	Cycle Group Holdings Limited completed the acquisition of Applied Therapeutics, Inc. for approximately $14.3 million.
03/02	Applied Therapeutics, Inc. Announces Management Changes
03/02	Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped from NASDAQ Composite Index
30/01	Cycle Pharmaceuticals Announces Further Extension of Applied Therapeutics Tender Offer
29/01	Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension
28/01	Applied Therapeutics, Inc.(NasdaqCM:APLT) dropped from S&P TMI Index
19/12	Applied Therapeutics, Inc.(NasdaqCM:APLT) dropped from NASDAQ Biotechnology Index
12/12	Cycle Group Holdings Limited entered into an agreement and plan of merger to acquire Applied Therapeutics, Inc. for $13.4 million.
11/12	Cycle Pharmaceuticals to Acquire Applied Therapeutics
20/11	Applied Therapeutics Announces Corporate Updates
20/11	Applied Therapeutics Announces Reduction of Workforce by Approximately 46%
14/11	Applied Therapeutics Reports Third Quarter 2025 Financial Results
13/11	Applied Therapeutics, Inc. Announces Resignation of John Johnson as Executive Chairman and as Director in November 2025
13/11	Applied Therapeutics Q3 net loss of $19 mln beats expectations
13/11	Applied Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
13/11	Applied Therapeutics Reports Third Quarter 2025 Financial Results
29/09/25	Applied Therapeutics Shares Slide After FDA Meeting on Govorestat
29/09/25	Applied Therapeutics Says Path Forward Not Determined for Govorestat; Shares Fall Pre-Bell
29/09/25	Applied Therapeutics provides update following meeting with FDA
29/09/25	Applied Therapeutics Provides Update Following Meeting with FDA
29/09/25	Applied Therapeutics, Inc. Provides Update Following Meeting with FDA
22/09/25	Applied Therapeutics, Inc.(NasdaqCM:APLT) dropped from S&P Global BMI Index
13/08/25	Applied Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
13/08/25	Applied Therapeutics Reports Second Quarter 2025 Financial Results
12/08/25	Applied Therapeutics says unaudited estimate of total stockholders' equity as of June 30 is about $17.4 mln